PHILADELPHIA, Pennsylvania, Sept. 9 -- Cancer Discovery, a peer-reviewed journal from the American Association for Cancer Research that says it describes major advances in research and clinical trials, published research articles on the following topics in its Sept. 1, 2024, edition (Vol. 14, Issue 9):

Research Briefs

* Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology G . . .

Click here for more information about our products